Iradimed Corp. (NASDAQ: IRMD) reported Q3 EPS of $0.43, $0.07 better than the analyst estimate of $0.36. Revenue for the quarter came in at $16.5 million versus the consensus estimate of $16.18 million.

For earnings history and earnings-related data on Iradimed Corp. (IRMD) click here.